Literature DB >> 11123931

Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.

A Clements1, K Johnston, J M Mazzarelli, R P Ricciardi, R Marmorstein.   

Abstract

Human papillomavirus 16 E7 (HPV16 E7) and adenovirus 5 E1A (Ad5 E1A) are encoded by highly divergent viruses yet are functionally similar in their ability to bind the retinoblastoma (pRB) tumor suppressor protein, causing the aberrant displacement of E2F trancription factors. The amino acid residues of HPV16 E7 that are necessary for stability, for inhibition of pRB function, and for cell transformation are also necessary for E7 oligomerization. However, neither the specific oligomerization state of HPV16 E7 nor of Ad5 E1A as a function of pRB-binding has been characterized. To gain insight into HPV16 E7 and Ad5 E1A oligomerization properties, sedimentation equilibrium experiments were performed with recombinant HPV16 E7 and Ad5 E1A proteins. These studies reveal that, despite the overall functional similarities between these proteins, monomers, dimers, and tetramers of HPV16 E7 were detected while only reversible monomer-dimer association was identified for Ad5 E1A. The apparent K(d(monomer)-(dimer)) of HPV16 E7 is approximately 100-fold lower than that of a comparable region of Ad5 E1A, and it is concluded that under physiological protein concentrations HPV16 E7 exists primarily as a dimer. Sedimentation equilibrium experiments of pRB/Ad5 E1A and of pRB/HPV16 E7 complexes demonstrate that the tight association of pRB with the viral oncoproteins does not disturb their inherent oligomerization properties. Taken together, this study demonstrates significant differences between the Ad5 E1A and HPV16 E7 oligomerization states that are potentially related to their distinct structures and specific mechanisms of pRB-inactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123931     DOI: 10.1021/bi002111g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  An effective system for detecting protein-protein interaction based on in vivo cleavage by PPV NIa protease.

Authors:  Nuoyan Zheng; Xiahe Huang; Bojiao Yin; Dan Wang; Qi Xie
Journal:  Protein Cell       Date:  2012-10-24       Impact factor: 14.870

2.  The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.

Authors:  Ariane L Jansma; Maria A Martinez-Yamout; Rong Liao; Peiqing Sun; H Jane Dyson; Peter E Wright
Journal:  J Mol Biol       Date:  2014-11-01       Impact factor: 5.469

3.  Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.

Authors:  Biljana Todorovic; Paola Massimi; Katherine Hung; Gary S Shaw; Lawrence Banks; Joe S Mymryk
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

4.  Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.

Authors:  Bing Xiao; James Spencer; Adrienne Clements; Nadeem Ali-Khan; Sibylle Mittnacht; Cristina Broceño; Manfred Burghammer; Anastassis Perrakis; Ronen Marmorstein; Steven J Gamblin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

5.  Modeling and molecular dynamics of the intrinsically disordered e7 proteins from high- and low-risk types of human papillomavirus.

Authors:  Nilson Nicolau; Silvana Giuliatti
Journal:  J Mol Model       Date:  2013-07-18       Impact factor: 1.810

6.  Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300.

Authors:  Daniela Fera; Ronen Marmorstein
Journal:  Biochemistry       Date:  2012-11-12       Impact factor: 3.162

Review 7.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

8.  Sequence evolution of the intrinsically disordered and globular domains of a model viral oncoprotein.

Authors:  Lucía B Chemes; Juliana Glavina; Leonardo G Alonso; Cristina Marino-Buslje; Gonzalo de Prat-Gay; Ignacio E Sánchez
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model.

Authors:  Linda Petrone; Maria G Ammendolia; Armando Cesolini; Stefano Caimi; Fabiana Superti; Colomba Giorgi; Paola Di Bonito
Journal:  J Transl Med       Date:  2011-05-18       Impact factor: 5.531

10.  Ordered self-assembly mechanism of a spherical oncoprotein oligomer triggered by zinc removal and stabilized by an intrinsically disordered domain.

Authors:  Clara Smal; Leonardo G Alonso; Diana E Wetzler; Angeles Heer; Gonzalo de Prat Gay
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.